• The determination of the level of quality of life as integral indicator of efficiency of complex treatment of pregnant women with irritable bowel syndrome 

The determination of the level of quality of life as integral indicator of efficiency of complex treatment of pregnant women with irritable bowel syndrome 

PERINATOLOGIYA I PEDIATRIYA.2016.1(65):51-54;doi 10.15574/PP.2016.65.51 
 

The determination of the level of quality of life as integral indicator of efficiency of complex treatment of pregnant women with irritable bowel syndrome 
 

Tuday V. M., Limanskaya A. J., Davydova J. V.

«Institute of Pediatrics, obstetrics, and gynecology NAMS of Ukraine», Kyiv 
 

The absence of the timely diagnostics and treatment of the irritable bowel syndrome in women of reproductive age deteriorates their quality of life and could become the cause of several pregnancy complications. 
 

Objective — to determine the level of quality of life as integral indicator of efficiency of complex treatment of pregnant women with irritable bowel syndrome. 
 

Patients and methods. Pregnant women were divided into two groups. The first group consisted of 50 women whose treatment included: diet; Mucofalk — 4 times a day for 20 days; probiotics (Probis—Femina) — 1 capsule 2 times a day for 14–18 days; correction of psychological state on the recommendations of the perinatal psychologist interview results; and in the presence of severe contamination of the vagina – use of modern disinfectant on the basis of hyaluronic acid of Ginoteca. The second group included 50 women with physiological pregnancy who did not receive the aforementioned treatment. 
 

Results. In the modern medicine is being taken seriously personalized approach to the treatment of the patient, therefore assessment of quality of life in irritable bowel syndrome, as an integral indicator is one of the main criteria of treatment effectiveness. Personification approach to the treatment of functional bowel diseases, based on the data of the levels of specific biomarkers indicating the state targeted for irritable bowel syndrome organ systems, psychological States, allows you to choose an effective therapy to prevent polypharmacy, to significantly improve the quality of life on average 16.7±2.3 points. 
 

Conclusions. The use of microbial interference therapy with the inclusion of modern probiotics Probes—Femina can significantly reduce contamination of the intestine and the vagina, reduce the clinical manifestations of irritable bowel syndrome, which is confirmed by the improvement of quality of life. Improving the quality of life achieved as a result of selecting individualized treatment is great importance for creating conditions for child bearing, substantially close to physiological. 
 

Key words: irritable bowel syndrome, pregnant women, assessment of quality of life. 
 

REFERENCES

1. Brandt LJ, Chey WD, Foxx-Orenstein AE et al. 2009. An evidence-based systematic review on the management of irritable bowel syndrome. Am J Gastroenterol. 104; Suppl 1: S1—S35. http://dx.doi.org/10.1038/ajg.2008.122; PMid:19521341

2. Burckhardt CS, Anderson KL. 2003. The Quality of Life Scale (QOLS): Reliability, Validity, and Utilization. Health and Quality of Life Outcomes. 1: 60. http://dx.doi.org/10.1186/1477-7525-1-60http://dx.doi.org/10.1186/1477-7525-1-59

3. Creed F, Ratcliffe J, Fernandez L et al. 2011. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med. 134: 860 — 868. http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00010

4. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther. 16; 6: 1171 — 1185. http://dx.doi.org/10.1046/j.1365-2036.2002.01290.x; PMid:12030961

5. Faresjo A, Anastasiou F, Lionis C et al. 2006. Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health and Quality of Life Outcomes. 4: 211. http://dx.doi.org/10.1186/1477-7525-4-21; PMid:16566821 PMCid:PMC1444922

6. Vanheel H, Farru R. 2013. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 10: 142—149. http://dx.doi.org/10.1038/nrgastro.2012.255

7. Quigley E, Fried M, Gwee KA et al. 2009. World Gastroenterology Organisation Global Guideline. Irritable bowel syndrome: a global perspective.